MolDx Program
Local Coverage Determinations Roundup: Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
MolDx Backs off Proposed LCD for Solid Organ Allograft Rejection Testing
Medicare administrative contractors plan to propose a new LCD in the coming months. Meanwhile, the existing coverage criteria remains.
Palmetto Declines to Cover Molecular Risk Stratification Tests for Cutaneous Squamous Cell Carcinoma
The three other Medicare administrative contractors that participate in the MolDx program aligned their coverage with Palmetto's.
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
NeoGenomics Raises Full-Year Guidance as Q3 Revenues Top Estimates
Third quarter revenue growth was driven by increasing clinical test volumes, a continuing shift to higher-complexity tests, and improvements in revenue per test.
Dec 8, 2022